Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
ATIII-Heparin inhibits which elements of the coagulation cascade?
|
Active serine proteases IXa, Xa, XIa, XIIa, VIIa.
ie, ATIII is a SERPIN Low levels of active ATIII are maintained to prevent unnecessary clots. |
|
Warfarin inhibits which elements of coagulation cascade?
How does it work? |
Inhibits ZYMOGEN form of serine proteases:
II (Prothrombin), VII, IX, X, It inhibits the Vitamin K dependent gamma-carboxylation of these serine proteases. Without gamma-carboxyl groups, they can't bind Ca+2 and are inactive. |
|
What are the non-enzyme cofactors?
Which enzymes require them? |
VIIIa- required by IXa
Tissue factor- required by VIIa Va- required by Xa |
|
ATII-Heparin
|
Irreversibly inhibits ALL serine proteases in cascade.
|
|
What is required for the cross-linking of Fibrin (Ia)?
|
XIIIa- this is not a protease, but rather a transglutaminase.
Cross-links Gln and Lys side chains in fibrin to create a clot. |
|
Steps in Intrinsic Pathway
|
Damaged surface
Kininogen and Kallikrein induce XII--> XIIa XIIa induces XI-->XIa XIa induces IX-->IXa IXa + VIIIa induces X-->Xa Xa + Va induces Prothrombin (II) --> Thrombin (IIa) IIa induces Fibrinogen (I)--> Fibrin (Ia) Fibrin Ia + XIIIa (transglu-ase) forms blood clots |
|
Steps in Extrinsic Pathway
|
Trauma
VII-->VIIa VIIa + TF induces X-->Xa Xa + Va induces Fibrinogen (I)--> Fibrin (Ia) Ia + XIIIa (transglu-ase) forms blood clots |
|
What makes up a clot
|
Fibrin (starts out as loose strings, then forms solid mesh via cross-links)
Trapped platelets & RBCs All this forms a scab |
|
What measures Extrinsic Pathway?
What is main inhibitor of EP? |
Prothrombin Time (PT)
Warfarin is main inhibitor |
|
What measures Intrinsic Pathway?
Main inhibitor of IP? |
Activated thromboplastin time (aPTT)
Heparin is main inhibitor |
|
PT and aPTT in relation to platelet function
|
These measurements use plasma rather than whole blood, so they don't measure platelet function
|
|
Platelet count
|
Should be above 50,000 per mm3
|
|
What inhibits platelet function?
|
Aspirin- irreversibly inhibits COX1 and COX2
Ibuprofen- Reversibly inhibits COX1 and COX2 |
|
How are platelets formed?
How long before having surgery should you stop taking Aspirin? |
Platelets form by budding off megakaryocytes, so lack a nucleus and cannot replace dead COX1 (as caused by Aspirin).
Half-life of platelets is 10 days, so need to stop taking Aspirin 10 days before surgery so new platelets can form that have functional COX1 |
|
Vitamin K
|
Needed for gamma-carboxylation of SERPINS II, VII, IX, and X to form gamma-carboxyglutamic acid residues (Gla)
Gla allows clotting factors to bind Ca+2, which anchors them to phospholipid membranes (to phosphatidyl serine) of the platelets at the injury site |
|
Phosphatidylserine
|
Normally on cytoplasmic side of lipid bilayers, but is on outside of activated platelets.
Gla residues w/Ca+2 bind to phosphatidylserine so the clotting factors are anchored to the platelets. |
|
How does Warfarin (Coumadin) work?
|
It inhibits the enzyme that reduces Vit K
Reduced Vit K is necessary for gamma-carboxyglutamation. Thus Ca+2 can't bind and the cofactors can't be anchored to phophatidylserines on platelets. |
|
Warfarin metabolism
|
Metabolized by cytochrome p450 system.
But at different rates in different people-->due to genetics. Can understand with pharmacogenomics. Warfarin contains a racemic mixture of R and S forms. S accts for 60-70% of anti-coag respone. R accts for 30-40% of response. Different p450s metabolize these at different rates, and since there are numerous p450 variations (~26), need to know which ones a person has. |
|
Cytochrome p450 variations
|
Very slow p450: 1/2 normal Vmax, 1/2 normal Kcat
Slow p450: 10x normal Km |
|
Heparin
Where in cells? How is it isolated? |
Drug used to control clotting.
Found in granules of mast cells. Isolated from intestinal mucosa of pigs. |
|
Contaminated Heparin
|
Contained Over Sulfated Chondroitin Sulfate (OSCS), which made Heparin appear to be very active for clotting inhibition, but in patients activated the complement cascade, producing anaphylactic responses & killing patients.
|
|
How does Heparin work?
|
Activates ATIII, a SERPIN that acts on proteases IX, X, XI, XII, and VII.
Heparin-like molecules on vessel endothelial cells activate ATIII and keep uncontrolled clotting from occuring. Heparin is also contained in mast cells, but it is bound tightly to serine proteases there and doesn't seem to have impact on clotting. |
|
How does ATIII work?
|
Has Arg in its inhibitor site. When heparin binds, conformation change occurs that allows it to react with Thrombin, etc in the cascade.
|
|
A1-AT Pittsburgh
|
Normal A1-AT acts on elastase, it does not require heparin for activation.
A1-AT Pitt has a Met-->Arg, so it works on thrombin instead of elastase, but still does not require heparin. Ie, its always active and prevents clotting--> Hemophilia. |
|
Factor VIII deficiency
|
Leads to hemophilia.
X-linked Recessive. Anti-hemophilic factor |
|
vWF
|
Glycoprotein that helps platelets to clump & stick to vessel wall by binding to proteins on platelets & collagen.
Also, carries VIII in the blood. VIII degrades quickly when not attached to vWF. |
|
vWF
|
Glycoprotein that helps platelets to clump & stick to vessel wall by binding to proteins on platelets & collagen.
Also, carries VIII in the blood. VIII degrades quickly when not attached to vWF. |
|
vWD
|
Deficiency results in poor platelet clumping & reduced VIII, so ineffective clotting.
Affects 1% of pop, men & women. |
|
Cryoprecipitate
|
Thawing of frozen blood plasma
Contains fibrinogen, vWF, FVIII, FXIII, and fibronectin. Used to treat vWF and FVIII deficiency. Does not contain FIX, so can't be used for that type of hemophilia. |
|
Protein C
|
slows coagulation by degrading Factors Va and VIIIa.
Activated because when enough thrombin has been produced to form fibrin, the excess thrombin binds to thrombomodulin on endothelial cells. |
|
Ways endothelial cells favor thrombosis:
|
Damage to wall exposes tissue factor, inducing extrinsic pathway.
Damage exposes collagen; vWF binds to collagen and to platelets to hold them in place. Fibrin holds platelet clot to damaged site on vessel |
|
Ways endothelial cells inhibit thrombosis:
|
Heparin-like molecules on ECs activate ATIII
TF inhibitors on ECs inactivates VIIa Thrombin bound to thrombomodulin on EC activates Protein C, degrading Va and VIIIa. ECs make PG12 and NO to inhibit platelet aggregating. ECs make tissue plasminogen activator-->degrades fibrin. |
|
Fibrinogen
|
Large, hexameric
2 each of alpha, beta, gamma chains Made by hepatocytes Cleaved by thrombin to produce fibrin |
|
Fibrin
|
Made when thrombin cleaves fibrinopeptides A and B from fibrinogen.
Removal of fibrinopeptides allows ionic bonds to form between fibrin strands. Goes from soluble fibrinogen to insoluble fibrin. |
|
XIIIa
|
Transglutaminase-
Forms crosslinks between Gln and Lys in Fibrin |
|
Plasminogen
|
A zymogen of plasmin, which degrades fibrin.
Activated by tissue plasminogen activator (tPA). |
|
tPA
|
tissue plasminogen activator. Yields active plasmin from plasminogen.
Can be injected into blood stream to treat clots clinically. |